Skip to main content
SMFM 2026 Pregnancy Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Additional registration fee required
Additional registration fee required
Faculty have requested this content not be shared outside of the session
Faculty have requested this content not be shared outside of the session
CME Credit Offered
CME Credit Offered
Abstract Award
Abstract Award
Recording available 2/16-5/2
Recording available 2/16-5/2
AIUM Credit
AIUM Credit
Foundation Awardee
Foundation Awardee
Poster Icons
Abstract Award
Abstract Award
Foundation Awardee
Foundation Awardee

Poster Session 3

Category: Health Equity/Community Health

Poster Session 3

(986) The impact of intimate partner substance use on relationship support and satisfaction in pregnancy

Thursday, February 12, 2026
10:30 AM - 12:00 PM  
Objective:
While having a partner may increase social support, the effect of partner substance use on support is unclear. We examined how partner substance use affects perceived social support, resiliency, finances, and relationship quality during pregnancy from the pregnant patient’s perspective.

Study Design:
This is a secondary analysis of the Pennsylvania (PA)-Maternal and Infant Health in a Pandemic study, a prospective survey study conducted at 4 PA health systems (8/23-5/25). We compared pregnant adults whose partners engaged in recreational substances during pregnancy to those whose did not. The primary outcome was social support (Modified Medical Outcomes Study Social Support Scale). Secondary outcomes included resiliency (Brief Resiliency Scale), financial strain, sexually transmitted infection (STI) exposure, conflict and coparenting dynamics (Coparenting Relationship Scale), birth control use, partner substance use during pregnancy, and relationship satisfaction. Demographics were described using means (+SD) and medians (IQR). The Kruskal Wallis and Chi-squared tests were used to analyze continuous and categorical bivariate associations, respectively. Generalized linear and logistic regression models were used to adjust for baseline differences; p-values of < 0.05 were considered significant.

Results:
2812 pregnancies were included. Partners who took substances were older and had an advanced degree (Table 1). Patients whose partners took substances were older, Caucasian (82.4% vs. 89.5%, p</span>< 0.01), took substances, were prescribed opioids, and experienced intimate partner violence. Adjusted analyses found no differences in perceived social support, resilience, financial strain, STI exposure, postpartum contraception, or relationship satisfaction (Table 2). Patients whose partners took substances reported more conflict and lower coparenting scores.

Conclusion:
Partners use of substances resulted in more reported conflict and worse coparenting dynamics, however, did not affect patients perceived support, resilience, financial strain, STI exposure, birth control use, or relationship happiness.